Answers are grounded in this paper and cite their sources.
Our findings suggest that inhibition of 14, 15-EET or inactivation of integrin αvβ3/FAK/PI3K/AKT pathway could serve as a novel approach to reverse EMT and cisplatin resistance in breast cancer cells.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: